China’s Shenzhen Mindray Bio-Medical Electronics has agreed to acquire HyTest, a supplier of raw materials used in tests for diseases such as COVID-19, to gain independence in making and developing core materials for testing reagents.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
